As a corporate Commonwealth entity and Government Business Enterprise, DHA plans and reports in accordance with the:

• Public Governance, Performance and Accountability Act 2013 (PGPA Act)
• Public Governance, Performance and Accountability Rule 2014 (PGPA Rule)
• Commonwealth Government Business Enterprise Governance and Oversight Guidelines (GBE Guidelines).

The Australian Government does not appropriate funds directly to DHA in the Federal Budget, however, information about DHA is included in the Department of Defence’s Portfolio Budget Statements as we are part of the Defence portfolio. The Defence Portfolio Statements outlines the outcome and the two purposes that DHA works to achieve (see Figure 3.1).

Figure 3.1: DHA's purposes 2019–20

DHA’s approach to planning and reporting (refer Figure 3.2) is consistent with the requirements of the Defence Housing Australia Act 1987 (DHA Act), PGPA Act and associated instruments and policies and the GBE Guidelines. DHA aims to provide high quality information to our Shareholder Ministers, the Parliament, our customers and the public through clearly linked and integrated planning and reporting.

Figure 3.2: DHA’s approach to planning and reporting 2019–20

Corporate Plan

In accordance with section 16E(4) of the PGPA Rule, the Board has chosen not to make our Corporate Plan publicly available to protect DHA’s commercial interests. Rather, we prepare and publish a Statement of Corporate Intent annually, based on our Corporate Plan. The Statement of Corporate Intent 2019–20 provides a high level, plain English overview of DHA’s key objectives and priorities for the financial year and was published in August 2019.

As set out in our Corporate Plan 2019–20, DHA developed a strategic canvas with four strategic priorities, goals, objectives and associated Key Performance Indicators (KPIs). The strategic canvas provides a framework for articulating the work we do to achieve the outcome mandated by Government through the fulfilment of our purposes (refer Figure 3.3).

Figure 3.3: DHA's Strategic Canvas 2019–20